Delivery Order SPE2DB20D1109-SPE2DB23FP50V
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,913.64 firm-fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support military and government healthcare programs. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $17,374.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to support military healthcare programs. The contract has an ultimate completion date of November 9, 2023, and is a firm fixed-price delivery order. The contract was awarded through full and open competition, with no set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,904.47 for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The Delivery Order contract, valued at $3,870.01, is for the procurement of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 7, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication for a ceiling value of $14,932.80. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price. The award date is March 13, 2023, and the ultimate completion date is March 14, 2023. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The award has a ceiling value of $6,966.24 and an ultimate completion date of January 29, 2024. The contract is a firm-fixed-price delivery order, and no set-aside was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award, valued at $5,739.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product, with a completion date of December 29, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. The contract was awarded on an open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,741.62 delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of May 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $2,946.27, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of March 7, 2024. There is no set-aside designation noted for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for $2,309.43 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP50VDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,389.43 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC. The contract does not have any set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/11/23 |